← Back to Clinical Trials
Recruiting NCT01731353

NCT01731353 FungiScope - A Global Emerging Fungal Infection Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT01731353
Status Recruiting
Phase
Sponsor University of Cologne
Condition Invasive Fungal Disease
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2003-03
Primary Completion 2026-12

Trial Parameters

Condition Invasive Fungal Disease
Sponsor University of Cologne
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2003-03
Completion 2026-12

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.

Eligibility Criteria

Inclusion Criteria: * Cultural, histopathological, antigen or DNA evidence of invasive fungal infection Exclusion Criteria: * Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci * Endemic fungal infection such as coccidioidomycosis or histoplasmosis * Colonisation or other non-invasive infection

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology